[Research Report] The Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size is expected to grow from US$ 550.68 million in 2022 to US$ 800.03 million by 2030; it is estimated to register the growth rate of 4.8% over the forecast period.
Market Insights and Analyst View:
Extracorporeal Membrane Oxygenation (ECMO) Systems are life support machines that are used to provide temporary assistance to severe respiratory or cardiac failure patients. The ECMO system works by removing blood from the patient’s body, oxygenating it outside of the body, and then returning it to the patient. These systems are used as a last resort when other treatments have failed. They are commonly employed in intensive care units and require specialized training and expertise to operate. ECMO Systems does not cure lung or heart damage; it just takes the load from the lungs and heart, which gives time for the organs to recover during treatment. The increasing prevalence of respiratory and cardiovascular conditions, along with the increase in cardiovascular surgeries among the geriatric population, is expected to drive the ECMO systems market. Moreover, increased use of ECMO systems among neonatal and pediatric patients is expected to create ample opportunities in the ECMO systems market growth.
Growth Drivers and Challenges:
Cardiopulmonary disorders are mainly affecting the lungs and heart of people. These conditions are classified as chronic obstructive pulmonary disease (COPD) and cardiovascular diseases. Cardiovascular diseases comprise blood vessel diseases, heart arrhythmia problems, coronary artery diseases, and heart defects that affect the blood vessels and heart. Further, COPD consists of chronic bronchitis and emphysema.
As per the American Lung Association, COPD is the prominent cause of death in the US, affecting ~12 million Americans in 2022. According to the WHO, COPD will be the third leading cause of death globally in 2021. The high COPD mortality rate is linked to acute exacerbations that cause failure of respiratory muscles, resulting in the loss of ability to breathe independently, which leads to death from systemic infection and asthma. Further, as per the Burden of Obstructive Lung Disease (BOLD) report, 2020, COPD mortality is projected to rise worldwide over the next 40 years, reaching 5.4 million deaths annually by 2060. Thus, with the rising incidence of COPD, the demand for ECMO systems is also on the rise.
As per the Global Health Data Exchange registry, the worldwide prevalence of congestive heart failure is 64.34 million cases in 2023. The primary risk factors of CVDs include ethnicity, family history, and age; other risk factors include hypertension, obesity, tobacco consumption, high cholesterol, physical inactivity, and diabetes. The WHO estimates that 17.9 million lives are lost due to CVDs annually. Oxygenator devices can be a key assistance to doctors to reduce the mortality rate. In the event of heart failure, the blood oxygen level is maintained with the assistance of an external device, as the heart is unable to maintain proper oxygen levels. Oxygenator devices are used to manage patients with heart failure.
Therefore, the rising prevalence of cardiopulmonary diseases (cardiovascular disorders and COPD) boosts the demand for ECMO systems.
However, there are various risk factors associated with the use of ECMO systems that can affect the patient's condition. Bleeding is one of the risk factors experienced among most of the patients with ECMO systems due to the use of anti-coagulant. Additionally, increased risk of stroke, infections, kidney failure, mechanical failure, and others are also observed in some of the cases, which is likely to hamper the ECMO systems market growth.
Strategic Insights
Report Segmentation and Scope:
The “Global ECMO Systems Market Size” is segmented based on modality, application, patient type, end user, and geography. Based on modality, the ECMO systems market is segmented into veno-arterial (VA), veno-venous (VV), and others. Based on application, the ECMO systems market is bifurcated into respiratory and cardiology. Based on patient type, the ECMO systems market is segmented into adult, pediatric, and neonatal. Based on end users, the ECMO systems market is categorized into hospitals and Clinics, cardiac centers, and others. The ECMO systems market based on geography is fragmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
Based on modality, the ECMO systems market size is segmented into veno-arterial (VA), veno-venous (VV), and others. In 2022, the veno-arterial segment held the largest share of the market and is expected to register the fastest rate during the coming years owing to the increased effectiveness and reliability of gas exchange along with widespread use among cardiac arrest patients as it helps with algorithm life support techniques to reestablish blood flow.
ECMO Systems Market, by Modality – 2022 and 2030
Based on application, the ECMO systems market is bifurcated into respiratory and cardiology. In 2022, the respiratory segment held the largest market share and is also expected to grow at the fastest rate during the coming years, owing to the increasing prevalence of respiratory disorders along with smoking and tobacco use, which can cause respiratory failure.
Based on patient type, the ECMO systems market is segmented into adult, pediatric, and neonatal. In 2022, the adult segment held the largest share of the market by patient type. However, the neonatal segment is expected to register the highest growth rate during the coming years owing to the increasing prevalence of respiratory conditions such as pneumonia, respiratory distress syndrome, and others among the neonatal population.
Based on end users, the ECMO systems market is categorized into hospitals and clinics, cardiac centers, and others. In 2022, the hospital and clinics segment held the major market share and is expected to register a significant growth rate during the coming years, owing to the increasing hospital admissions for respiratory conditions to receive treatment and care for the required duration.
Regional Analysis:
The ECMO systems market encompasses five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2022, North America held the largest ECMO systems market share, closely followed by Europe, and Asia Pacific is estimated to register the highest CAGR during the forecast period. The major growth factor for the North American market is the rising prevalence of cardiovascular and respiratory disorders in the region. It has increased the incidence of cardiopulmonary disorders such as COPD, chronic bronchitis, congestive heart failure, and others. According to the American Lung Association, there were ~12.5 million people diagnosed with chronic bronchitis, COPD, and emphysema in the US in 2020.
Additionally, the rising incidence and prevalence of these disorders have increased the count of surgical procedures among large patient populations, which has fueled the growth of the ECMO systems market. For instance, in the Lifespan health system study, there were ~500,00 open heart surgeries performed every year in the US. Additionally, the rising prevalence of respiratory failure and infectious diseases is further expected to create demand for ECMO systems.
Furthermore, the increasing prevalence of CVDs is the leading cause of death on the global level, and ECMO systems can be of great assistance in lifesaving in emergencies. As per the WHO, ~17.9 million lives are lost due to CVD every year, and favorable reimbursement policies are also likely to create ample opportunities for the growth of ECMO systems. Therefore, the increasing prevalence and prevalence of cardiopulmonary disorders are expected to lead to the growth of the ECMO systems market during the forecast period.
However, Asia Pacific is registered as the fastest-growing region in the global ECMO systems market. The market in this region is expected to increase significantly in countries such as China, Japan, and India. The market's growth is attributed to the increasing focus of market players in developing economies and supportive government policies. Although the availability of effective and safe prevention strategies worldwide, cardiovascular disease (CVD) remains the leading cause of death and premature death globally. The growth of the market is mainly attributed to the increasing prevalence of atrial fibrillation (AF) in China, the increasing burden of various other heart diseases, and the rising geriatric population across the region are all expected to support market growth. As per the prediction done by the World Heart Federation, cardiovascular events like ischemic heart disease and stroke are expected to rise by 50% among the Chinese population between 2010 and 2030. The Indian Heart Association stated that 50% of heart attacks occur under the age of 50, while 25% of heart attacks occur under 25 years of age. Both the male and female populations in the country equally exhibit the risk of developing heart disease.
Moreover, stroke is one of atrial fibrillation's frequent and devastating complications. About one-third of the patients with atrial fibrillation are asymptomatic, and atrial fibrillation may go undetected in the patients until symptoms develop. As the oxygenator supplies oxygen, by removing carbon dioxide, to the artery during heart surgeries, the heart is relieved from performing pumping duties. Thus, the growing prevalence of cardiovascular disease in the region is fueling the demand for the ECMO systems market.
According to the Frontier Media Public Health report published in June 2022, the most recent Chinese national survey of COPD showed that China accounted for almost 25% of all COPD cases globally. As compared with the survey results ten years ago, the prevalence of COPD has increased by 67% in the aged 40 years or older group and has reached epidemic proportions. Moreover, the beginning of the COVID-19 pandemic in Wuhan City in China led to the development of severe acute respiratory syndrome among the large population, which in turn created the demand for the ECMO systems market. Moreover, during the COVID-19 pandemic, India was the second most affected country in the region, with the second highest number of cases with different waves of COVID-19, which has raised the growth of the ECMO systems market.
Therefore, the growing prevalence of cardiovascular as well as respiratory diseases in the population of Asia Pacific is fueling the demand for ECMO systems.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global ECMO systems market are listed below:
- In January 2023, Chinabridge Medical officially launched the first domestically developed extracorporeal membrane oxygenation (ECMO) machine that will help in the treatment of COVID-19 patients in critical condition and boost the development of the country's high-end medical devices. National Medical Products Administration approves it for emergency use within China.
- In November 2022, LivaNova PLC was granted US Food and Drug Administration (FDA) 510(k) for extracorporeal membrane oxygenation (ECMO), LifeSPARC. LivaNova leveraged existing real-world evidence, inclusive of data collected during the COVID-19 pandemic, to receive this new indication.
- In February 2020, Fresenius Medical Care's Novalung was approved by the FDA for the treatment of acute respiratory or cardiopulmonary failure. Novalung is the first extracorporeal membrane oxygenation (ECMO) system to be cleared for more than six hours of use as extracorporeal life support.
Competitive Landscape and Key Companies:
Some of the major players operating in the global ECMO systems market include LivaNova (Alung Technologies Inc.), Eurosets, Getinge AB, Medtronic PLC, Microport Scientific Corporation, Inspira Technologies, Terumo Medical Corporation, Abbott Laboratories, Fresenius Medical Care Company (Xenios AG), and Chinabridge Medical among others. These companies focus on geographical expansions, new product launches, strategic collaboration, and product approval to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which allows them to serve a large set of customers and subsequently increase their market share.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Extracorporeal Membrane Oxygenation System Market - By Component
1.3.2 Extracorporeal Membrane Oxygenation System Market - By Modality
1.3.3 Extracorporeal Membrane Oxygenation System Market - By Application
1.3.4 Extracorporeal Membrane Oxygenation System Market - By Patient Type
1.3.5 Extracorporeal Membrane Oxygenation System Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET - GLOBAL MARKET ANALYSIS
6.1. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM - GLOBAL MARKET OVERVIEW
6.2. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - COMPONENT
7.1. OVERVIEW
7.2. COMPONENT MARKET FORECASTS AND ANALYSIS
7.3. PUMPS
7.3.1. Overview
7.3.2. Pumps Market Forecast and Analysis
7.4. OXYGENATORS
7.4.1. Overview
7.4.2. Oxygenators Market Forecast and Analysis
7.5. CONTROLLERS
7.5.1. Overview
7.5.2. Controllers Market Forecast and Analysis
7.6. CANNULA
7.6.1. Overview
7.6.2. Cannula Market Forecast and Analysis
7.7. ACCESSORIES
7.7.1. Overview
7.7.2. Accessories Market Forecast and Analysis
8. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - MODALITY
8.1. OVERVIEW
8.2. MODALITY MARKET FORECASTS AND ANALYSIS
8.3. VENOARTERIAL (VA)
8.3.1. Overview
8.3.2. Venoarterial (VA) Market Forecast and Analysis
8.4. VENOVENOUS (VV)
8.4.1. Overview
8.4.2. Venovenous (VV) Market Forecast and Analysis
8.5. ARTERIOVENOUS (AV)
8.5.1. Overview
8.5.2. Arteriovenous (AV) Market Forecast and Analysis
9. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. RESPIRATORY
9.3.1. Overview
9.3.2. Respiratory Market Forecast and Analysis
9.4. CARDIAC
9.4.1. Overview
9.4.2. Cardiac Market Forecast and Analysis
9.5. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
9.5.1. Overview
9.5.2. Extracorporeal Cardiopulmonary Resuscitation (ECPR) Market Forecast and Analysis
10. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - PATIENT TYPE
10.1. OVERVIEW
10.2. PATIENT TYPE MARKET FORECASTS AND ANALYSIS
10.3. NEONATES
10.3.1. Overview
10.3.2. Neonates Market Forecast and Analysis
10.4. PEDIATRIC
10.4.1. Overview
10.4.2. Pediatric Market Forecast and Analysis
10.5. ADULT
10.5.1. Overview
10.5.2. Adult Market Forecast and Analysis
11. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Extracorporeal Membrane Oxygenation System Market Overview
11.1.2 North America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis
11.1.3 North America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Component
11.1.4 North America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Modality
11.1.5 North America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Application
11.1.6 North America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Patient Type
11.1.7 North America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Countries
11.1.7.1 United States Extracorporeal Membrane Oxygenation System Market
11.1.7.1.1 United States Extracorporeal Membrane Oxygenation System Market by Component
11.1.7.1.2 United States Extracorporeal Membrane Oxygenation System Market by Modality
11.1.7.1.3 United States Extracorporeal Membrane Oxygenation System Market by Application
11.1.7.1.4 United States Extracorporeal Membrane Oxygenation System Market by Patient Type
11.1.7.2 Canada Extracorporeal Membrane Oxygenation System Market
11.1.7.2.1 Canada Extracorporeal Membrane Oxygenation System Market by Component
11.1.7.2.2 Canada Extracorporeal Membrane Oxygenation System Market by Modality
11.1.7.2.3 Canada Extracorporeal Membrane Oxygenation System Market by Application
11.1.7.2.4 Canada Extracorporeal Membrane Oxygenation System Market by Patient Type
11.1.7.3 Mexico Extracorporeal Membrane Oxygenation System Market
11.1.7.3.1 Mexico Extracorporeal Membrane Oxygenation System Market by Component
11.1.7.3.2 Mexico Extracorporeal Membrane Oxygenation System Market by Modality
11.1.7.3.3 Mexico Extracorporeal Membrane Oxygenation System Market by Application
11.1.7.3.4 Mexico Extracorporeal Membrane Oxygenation System Market by Patient Type
11.2. EUROPE
11.2.1 Europe Extracorporeal Membrane Oxygenation System Market Overview
11.2.2 Europe Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis
11.2.3 Europe Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Component
11.2.4 Europe Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Modality
11.2.5 Europe Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Application
11.2.6 Europe Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Patient Type
11.2.7 Europe Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Extracorporeal Membrane Oxygenation System Market
11.2.7.1.1 Germany Extracorporeal Membrane Oxygenation System Market by Component
11.2.7.1.2 Germany Extracorporeal Membrane Oxygenation System Market by Modality
11.2.7.1.3 Germany Extracorporeal Membrane Oxygenation System Market by Application
11.2.7.1.4 Germany Extracorporeal Membrane Oxygenation System Market by Patient Type
11.2.7.2 France Extracorporeal Membrane Oxygenation System Market
11.2.7.2.1 France Extracorporeal Membrane Oxygenation System Market by Component
11.2.7.2.2 France Extracorporeal Membrane Oxygenation System Market by Modality
11.2.7.2.3 France Extracorporeal Membrane Oxygenation System Market by Application
11.2.7.2.4 France Extracorporeal Membrane Oxygenation System Market by Patient Type
11.2.7.3 Italy Extracorporeal Membrane Oxygenation System Market
11.2.7.3.1 Italy Extracorporeal Membrane Oxygenation System Market by Component
11.2.7.3.2 Italy Extracorporeal Membrane Oxygenation System Market by Modality
11.2.7.3.3 Italy Extracorporeal Membrane Oxygenation System Market by Application
11.2.7.3.4 Italy Extracorporeal Membrane Oxygenation System Market by Patient Type
11.2.7.4 Spain Extracorporeal Membrane Oxygenation System Market
11.2.7.4.1 Spain Extracorporeal Membrane Oxygenation System Market by Component
11.2.7.4.2 Spain Extracorporeal Membrane Oxygenation System Market by Modality
11.2.7.4.3 Spain Extracorporeal Membrane Oxygenation System Market by Application
11.2.7.4.4 Spain Extracorporeal Membrane Oxygenation System Market by Patient Type
11.2.7.5 United Kingdom Extracorporeal Membrane Oxygenation System Market
11.2.7.5.1 United Kingdom Extracorporeal Membrane Oxygenation System Market by Component
11.2.7.5.2 United Kingdom Extracorporeal Membrane Oxygenation System Market by Modality
11.2.7.5.3 United Kingdom Extracorporeal Membrane Oxygenation System Market by Application
11.2.7.5.4 United Kingdom Extracorporeal Membrane Oxygenation System Market by Patient Type
11.2.7.6 Rest of Europe Extracorporeal Membrane Oxygenation System Market
11.2.7.6.1 Rest of Europe Extracorporeal Membrane Oxygenation System Market by Component
11.2.7.6.2 Rest of Europe Extracorporeal Membrane Oxygenation System Market by Modality
11.2.7.6.3 Rest of Europe Extracorporeal Membrane Oxygenation System Market by Application
11.2.7.6.4 Rest of Europe Extracorporeal Membrane Oxygenation System Market by Patient Type
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Extracorporeal Membrane Oxygenation System Market Overview
11.3.2 Asia-Pacific Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis
11.3.3 Asia-Pacific Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Component
11.3.4 Asia-Pacific Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Modality
11.3.5 Asia-Pacific Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Patient Type
11.3.7 Asia-Pacific Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Extracorporeal Membrane Oxygenation System Market
11.3.7.1.1 Australia Extracorporeal Membrane Oxygenation System Market by Component
11.3.7.1.2 Australia Extracorporeal Membrane Oxygenation System Market by Modality
11.3.7.1.3 Australia Extracorporeal Membrane Oxygenation System Market by Application
11.3.7.1.4 Australia Extracorporeal Membrane Oxygenation System Market by Patient Type
11.3.7.2 China Extracorporeal Membrane Oxygenation System Market
11.3.7.2.1 China Extracorporeal Membrane Oxygenation System Market by Component
11.3.7.2.2 China Extracorporeal Membrane Oxygenation System Market by Modality
11.3.7.2.3 China Extracorporeal Membrane Oxygenation System Market by Application
11.3.7.2.4 China Extracorporeal Membrane Oxygenation System Market by Patient Type
11.3.7.3 India Extracorporeal Membrane Oxygenation System Market
11.3.7.3.1 India Extracorporeal Membrane Oxygenation System Market by Component
11.3.7.3.2 India Extracorporeal Membrane Oxygenation System Market by Modality
11.3.7.3.3 India Extracorporeal Membrane Oxygenation System Market by Application
11.3.7.3.4 India Extracorporeal Membrane Oxygenation System Market by Patient Type
11.3.7.4 Japan Extracorporeal Membrane Oxygenation System Market
11.3.7.4.1 Japan Extracorporeal Membrane Oxygenation System Market by Component
11.3.7.4.2 Japan Extracorporeal Membrane Oxygenation System Market by Modality
11.3.7.4.3 Japan Extracorporeal Membrane Oxygenation System Market by Application
11.3.7.4.4 Japan Extracorporeal Membrane Oxygenation System Market by Patient Type
11.3.7.5 South Korea Extracorporeal Membrane Oxygenation System Market
11.3.7.5.1 South Korea Extracorporeal Membrane Oxygenation System Market by Component
11.3.7.5.2 South Korea Extracorporeal Membrane Oxygenation System Market by Modality
11.3.7.5.3 South Korea Extracorporeal Membrane Oxygenation System Market by Application
11.3.7.5.4 South Korea Extracorporeal Membrane Oxygenation System Market by Patient Type
11.3.7.6 Rest of Asia-Pacific Extracorporeal Membrane Oxygenation System Market
11.3.7.6.1 Rest of Asia-Pacific Extracorporeal Membrane Oxygenation System Market by Component
11.3.7.6.2 Rest of Asia-Pacific Extracorporeal Membrane Oxygenation System Market by Modality
11.3.7.6.3 Rest of Asia-Pacific Extracorporeal Membrane Oxygenation System Market by Application
11.3.7.6.4 Rest of Asia-Pacific Extracorporeal Membrane Oxygenation System Market by Patient Type
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Overview
11.4.2 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis
11.4.3 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Component
11.4.4 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Modality
11.4.5 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Patient Type
11.4.7 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Extracorporeal Membrane Oxygenation System Market
11.4.7.1.1 South Africa Extracorporeal Membrane Oxygenation System Market by Component
11.4.7.1.2 South Africa Extracorporeal Membrane Oxygenation System Market by Modality
11.4.7.1.3 South Africa Extracorporeal Membrane Oxygenation System Market by Application
11.4.7.1.4 South Africa Extracorporeal Membrane Oxygenation System Market by Patient Type
11.4.7.2 Saudi Arabia Extracorporeal Membrane Oxygenation System Market
11.4.7.2.1 Saudi Arabia Extracorporeal Membrane Oxygenation System Market by Component
11.4.7.2.2 Saudi Arabia Extracorporeal Membrane Oxygenation System Market by Modality
11.4.7.2.3 Saudi Arabia Extracorporeal Membrane Oxygenation System Market by Application
11.4.7.2.4 Saudi Arabia Extracorporeal Membrane Oxygenation System Market by Patient Type
11.4.7.3 U.A.E Extracorporeal Membrane Oxygenation System Market
11.4.7.3.1 U.A.E Extracorporeal Membrane Oxygenation System Market by Component
11.4.7.3.2 U.A.E Extracorporeal Membrane Oxygenation System Market by Modality
11.4.7.3.3 U.A.E Extracorporeal Membrane Oxygenation System Market by Application
11.4.7.3.4 U.A.E Extracorporeal Membrane Oxygenation System Market by Patient Type
11.4.7.4 Rest of Middle East and Africa Extracorporeal Membrane Oxygenation System Market
11.4.7.4.1 Rest of Middle East and Africa Extracorporeal Membrane Oxygenation System Market by Component
11.4.7.4.2 Rest of Middle East and Africa Extracorporeal Membrane Oxygenation System Market by Modality
11.4.7.4.3 Rest of Middle East and Africa Extracorporeal Membrane Oxygenation System Market by Application
11.4.7.4.4 Rest of Middle East and Africa Extracorporeal Membrane Oxygenation System Market by Patient Type
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Extracorporeal Membrane Oxygenation System Market Overview
11.5.2 South and Central America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis
11.5.3 South and Central America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Component
11.5.4 South and Central America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Modality
11.5.5 South and Central America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Application
11.5.6 South and Central America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Patient Type
11.5.7 South and Central America Extracorporeal Membrane Oxygenation System Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Extracorporeal Membrane Oxygenation System Market
11.5.7.1.1 Brazil Extracorporeal Membrane Oxygenation System Market by Component
11.5.7.1.2 Brazil Extracorporeal Membrane Oxygenation System Market by Modality
11.5.7.1.3 Brazil Extracorporeal Membrane Oxygenation System Market by Application
11.5.7.1.4 Brazil Extracorporeal Membrane Oxygenation System Market by Patient Type
11.5.7.2 Argentina Extracorporeal Membrane Oxygenation System Market
11.5.7.2.1 Argentina Extracorporeal Membrane Oxygenation System Market by Component
11.5.7.2.2 Argentina Extracorporeal Membrane Oxygenation System Market by Modality
11.5.7.2.3 Argentina Extracorporeal Membrane Oxygenation System Market by Application
11.5.7.2.4 Argentina Extracorporeal Membrane Oxygenation System Market by Patient Type
11.5.7.3 Rest of South and Central America Extracorporeal Membrane Oxygenation System Market
11.5.7.3.1 Rest of South and Central America Extracorporeal Membrane Oxygenation System Market by Component
11.5.7.3.2 Rest of South and Central America Extracorporeal Membrane Oxygenation System Market by Modality
11.5.7.3.3 Rest of South and Central America Extracorporeal Membrane Oxygenation System Market by Application
11.5.7.3.4 Rest of South and Central America Extracorporeal Membrane Oxygenation System Market by Patient Type
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET, KEY COMPANY PROFILES
14.1. GETINGE GROUP
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. MEDTRONIC PLC
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. LIVANOVA PLC
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. XENIOS AG
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. TERUMO CORPORATION
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MICROPORT SCIENTIFIC CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. NIPRO CORPORATION
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ORIGEN BIOMEDICAL, INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ALUNG TECHNOLOGIES, INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. EUROSETS S.R.L
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
14.11. MAQUET HOLDING B.V. AND CO. KG
14.11.1. Key Facts
14.11.2. Business Description
14.11.3. Products and Services
14.11.4. Financial Overview
14.11.5. SWOT Analysis
14.11.6. Key Developments
14.12. SORIN GROUP
The List of Companies
1. Getinge Group
2. Medtronic plc
3. LivaNova PLC
4. XENIOS AG
5. Terumo Corporation
6. MicroPort Scientific Corporation
7. NIPRO Corporation
8. OriGen Biomedical, Inc.
9. ALung Technologies, Inc.
10. EUROSETS S.r.l
11. MAQUET Holding B.V. & Co. KG
12. Sorin Group
13. Medos Medizintechnik AG
14. Abbott Laboratories
15. Braile Biomedical
16. Edwards Lifesciences Corp
17. Elsius Biomedical Inc.
18. Spectrum Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Extracorporeal Membrane Oxygenation (ECMO) Systems Market
Apr 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)